期刊文献+

Ki67反义寡核苷酸及联合紫杉醇对PC-3细胞增殖的影响 被引量:1

Inhibition Effect of Ki67 AS-ODN and Its Combination with Paclitaxel on PC-3 Cells
下载PDF
导出
摘要 目的研究Ki67反义寡核苷酸(antisense oligodexynucleotides,AS-ODN)对人前列腺癌PC-3细胞增殖的抑制作用及与紫杉醇联用的协同作用。方法Ki67反义寡核苷酸在脂质体介导下转染PC-3细胞,以RT-PCR技术检测Ki67基因表达情况,以CCK8法检测Ki67反义寡核苷酸以及联合紫杉醇对PC-3细胞增殖的影响,以金正均Q值法评价二者是否有协同作用。结果31.25nmol/LAS-ODN能显著抑制PC-3细胞的增殖(P<0.05),且抑制作用随AS-ODN浓度增加而增强;各不同浓度的AS-ODN能显著降低Ki67 mRNA的表达;31.25nmol/LAS-ODN与0.001μmol/L紫杉醇联用,Q=1.77。结论Ki67反义寡核苷酸可以通过抑制增殖蛋白Ki67的表达进而抑制PC-3细胞的增殖,且与紫杉醇(0.001μmol/L)联用有协同作用。 Objective To investigate the inhibition effect of Ki67 AS - ODN on prostate carcinoma PC - 3 cells, and its possible synergism existing in combination of Ki67 AS - ODN and paclitaxel. Methods Ki67 AS - ODN were transfected into PC - 3 cells by lipofectamine. Cell proliferation was measured by CCK8 method, and Ki67 mRNA expression was detected by RT - PCR. The synergetic effect of Ki67 AS - ODN combined with paclitaxel was evaluated by Zhengjun Jin Q method. Results AS - ODN at the concentration of 31.25 nmol /L can significantly inhibit PC - 3 cells proliferation ( P 〈 0. 05), and the effect was dose - dependent. AS - ODN at different concentrations can decrease Ki67 mRNA expression. When 31.25 nmol/L AS - ODN were used together with 0. 001 μmol/L paclitaxel, Q = 1.77. Conclusion Ki67 AS - ODN can inhibit the proliferation of PC - 3 cells through decreasing Ki67 mRNA expression, and have a synergistic effect when combined with paclitaxel at the concentration of 0. 001μmol/L.
出处 《中药新药与临床药理》 CAS CSCD 2008年第4期275-277,共3页 Traditional Chinese Drug Research and Clinical Pharmacology
基金 广东省医学科学技术研究基金(A2005805)
关键词 前列腺癌细胞 KI67 反义寡核苷酸 紫杉醇 Prostate carcinoma cells Ki67 AS - ODN Paclitaxel
  • 相关文献

参考文献5

二级参考文献86

共引文献198

同被引文献14

  • 1Gerdes J,Schwab U,Lemke H,et al.Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.Int-J-.Cencer,1983;31:13-20.
  • 2Ninomyi,Yonmural,Metsumeto H.Expression of C-Myc gene produt in gastric carcinoma.Oncology,1991;48:149-153.
  • 3汤钊猷.现代肿瘤学.第2版.上海:上海医科大学出版社.2001,198-199,125-126.
  • 4Rivard N L,Allemain G,Bartek J,et al.Abrogation of P27 Kipl by cDNA antigense suppresses quiescence(Go state) in fibroblasts.J-Biol-Chem,1996;271(31):18337-18341.
  • 5JIA-qing Li,Mike H,Ohmoto M,et al.Expression of cyclin E and Cyclin-Dependent kinase 2 correlates with metastases and prognosis in 48 colorectal carcinoma.H-path,2001;32(9):951.
  • 6Aaltomaa S,Eskelinen M,Lipponen P,et al.Expression of cyclinA and D protein in prostate cancer and their relation to clinopathological varicalbles and patieat survival.Prostate,1999;38(3):175-182.
  • 7Voldborg B R,Damstrup L,Spang-Thomsen M,et al.Oncogene proteins and proliferation antigens in thymomas in creased expression of epidermal growth factor and epidermal growth factor receptor mutations,function and possible role in clinical trials.Ann-Oncol,1997;8(12):1197-1206.
  • 8Osman l,Scher HI,Zhang IJ,et al.Alterations affecting the P53 control path way in biharzial-related bladder cancer.Clin-Cancer-Res,1997;3(4):531-536.
  • 9Cher M L,Robert A,Stephenson B C,et al.Cellular proliferative Fraction of metastatic lymph Nodes predicts survival in stage D1(TxN+MO)Prostate cancer.J-Urology,1996;155:1674-1677.
  • 10Muneyuki M,Naoya H,Torahiko N,et al.Cyclin D1 over-expression in primary hypopharyngeal carcinomas.Cancer,1996;78(3):390-395.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部